Cargando…
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
Ewing sarcoma is an aggressive neoplasm predominantly occurring in adolescents and has a poor prognosis when metastasized. For patients with metastatic disease in particular, immunotherapy has been proposed as possible beneficial additive therapy. CCL21 activation-based immunotherapy was successful...
Autores principales: | Sand, Laurens G. L., Berghuis, Dagmar, Szuhai, Karoly, Hogendoorn, Pancras C. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956712/ https://www.ncbi.nlm.nih.gov/pubmed/27369431 http://dx.doi.org/10.1007/s00262-016-1862-1 |
Ejemplares similares
-
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes
por: Sand, Laurens G. L., et al.
Publicado: (2015) -
Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma
por: Sand, Laurens G. L., et al.
Publicado: (2017) -
The clinical use of biomarkers as prognostic factors in Ewing sarcoma
por: van Maldegem, Annmeik M, et al.
Publicado: (2012) -
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
por: Berghuis, Dagmar, et al.
Publicado: (2012) -
Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis
por: Berghuis, Dagmar, et al.
Publicado: (2012)